We investigated the influence of the extract of soy protein fermented with lactic acid bacteria and yeast (ESFL) on 1,2-dimethylhydrazine (DMH)-induced colon cancer and aberrant crypt foci (ACF) in ICR female mice. In all the experiments, 8-week old mice were given subcutaneous DMH injections at 35 mg/kg once a week. In the experiment for colon cancer, mice were divided into groups A, B and C, with 20 mice each, and groups A and B were given DMHinjections for 10 weeks. Group C were injected with only PBS. Group A were fed a 5%-ESFL diet and groups B and C were fed normal mouse diets throughout the experiment for 35 weeks. Group A showed a 28.5 % inhibition in incidence and a 59.1 % inhibition in average number of tumors compared to group B, but the results were not statistically significant. In ACF experiments, mice were divided into 4 groups, 10 % -ESFL group, 1 %-ESFL group, 0.1 % -ESFL group, and a control with 10 mice each. All the mice were given DMH injections for 4 weeks. ESFL-supplemented diets were given throughout the experiment for 8 weeks. ACF formation decreased in all the ESFL-fed groups in a dose-dependent manner and the results were statistically significant in the 10 %-ESFL group (69 % inhibition, p < 0.001) and 1 %-ESFL group (40% inhibition, p < 0.05) compared to the control. The present study suggests that ESFL could contain an effective anticarcinogenic substance(s).
INTRODUCTION
Colon cancer, which was rare in Japan, has been increasing recently among Japanese people, and the increase is attributed to the growing consumption of animal fat in the modern Japanese diet (19, 34) . A traditional Japanese diet contains not only little animal saturated fat but employs many soy foods, such as miso (fermented soybean paste), natto (fermented soybean), soy sauce and tofu (soy curd).
There are many reports that fermented soy foods have a preventive effect on cancer. An epidemiological study showed a strong association between consumption of miso soup and a reduction of gastric cancer mortality (12). Miso prevented N-nitroso-N-methylurea-induced mammary cancer in rats (8) and soy sauce inhibited benzo [a] pyrene-induced mouse forestomach neoplasia (4, 13, 21) . With regard to colon cancer, reports on the preventive effect of miso on azoxymethane-induced aberrant crypt foci (ACF) in rats have recently been published (17, 22) . Therefore, the lower amount of animal fat and the higher amount of fermented soy foods in a traditional Japanese diet may partly explain the reason why colon cancer was seen less in Japan than in Western countries.
Miso and soy sauce are mainly made of soybeans which are fermented with fungi, yeasts and lactic acid bacteria (LAB). The preventive effects of both soybeans and LAB on colon cancer have been also demonstrated in many reports. In epidemiological studies, soy protein was associated with a low risk of colon cancer in Asian populations (1) . In animal models, soy protein protected against azoxymethane-induced colon cancer (3, 9) . LAB, including Bifidobacteria, also have preventive effects on colon cancer, which were mostly examined in animal models (7, 28, 30) .
In Japan, there is a soy protein product designated "the extract of soy protein fermented with LAB and yeasts (ESFL)." The product is categorized and sold as a health food, and is widely consumed among healthconscious people in Japan. The major component of the product is a soy protein medium cultured with LAB and yeasts. Because ESFL is made of soy protein fermented with LAB and yeasts, it is naturally expected For the colon cancer experiment, 60 ICR mice were divided into 3 groups, groups A, B and C, with 20 mice in each group. From groups A and B, 40 mice were injected with the DMH solution for 10 weeks. Group C were injected with only PBS. A 5%-ESFL supplemented diet was given group A from the day of the first injection, day 0, until the day of sacrifice. Groups B and C were given a normal mouse diet, CMF. Body weights of mice were checked weekly and they were sacrificed 35 weeks after day 0. The colon was dissected, cut lengthwise, and the contents were removed. The number of tumors were counted, and the width and length of each tumor was measured with a micrometer. All the mice which had died during the experimental period were excluded from analysis. Lesions of tumors were stained with hematoxylin and eosin for histology.
For the experiment of aberrant crypt (AC) foci (ACF), 40 ICR mice were divided into 4 groups: 10% group, 1% group, 0.1% group and a control one. All the mice were given DMH injections sc once a week for four weeks. The 10%, 1% and 0.1% groups were respectively given 10%, 1%, and 0.1% ESFL-supplemented diets. The control group was given only CMF. The diets were fed to the mice from the start to the end of the experiment, and mice were sacrificed 8 weeks after day 0, based on our preceding experiments. The colon was dissected, cut open lengthwise, pinned on a cork board to be fixed with 10% formalin/PBS overnight, and stained with 0.2% methylene blue/PBS for 5 min. AC (Top; experiment for colon cancer) ICR mice were injected sc with DMH (35 mg/kg) or PBS once a week for 10 weeks and sacrificed 35 weeks after day 0. An ESFL-supplemented diet at 5% or CMF were given the mice throughout the experiment. (Bottom; experiment for ACF) ICR mice were injected sc with DMH (35 mg/kg) once a week for 4 weeks and sacrificed 8 weeks after day 0. Diets supplemented with ESFL at 10, 1, 0.1% or CMF were given the mice throughout the experiment. The average body weights in Group A were bigger than those in Group B from the 20th week to the end but there was no significant difference among the 3 groups throughout the experiment . Figure 2 shows changes in body weights of the mice affect the body weight of mice (data not shown). Table  2 expresses general observations of the experiment. The average spleen weight of group B was significantly higher than that of group C (p < 0.05). short chain fructo-oligosaccharides increased LAB in the intestines of mice, which would have resulted in the reduction of colon cancer. As another mechanism for LAB to prevent colon cancer, LAB may excrete mutagens from food by physically binding them together (23). LAB in ESFL are dead. Thus, heat-killed bodies of LAB may have influenced colon cancer and ACF formation by activating the gut-associated immune system of mice and/or by excreting potential promoters in the intestines from their bodies.
Inhibitory Effect of ESFL on Colon Cancer
Substances produced during fermentation have been drawing attention to other anticarcinogens in foods, as well as LAB and soy isoflavones. Melanoidins (MEL) are a brown pigmentary substance produced by Maillard reactions in the process of heating or aging foods. Fermented soy foods such as miso are rich in MEL and its anticarcinogenic activity has been reported (38) . MEL scavenges active oxygen (10), and act as a trypsin inhibitor (11).
Soy peptides are another factor. Soy proteins are digested into peptides during fermentation and their antioxidative and immunostimulating effects have been reported (20, 39). Other functional substances, which are still unknown, are expected to exist in fermented foods.
The major purpose of the present study was to observe whether ESFL would have inhibitory effects on colon cancer in an animal model, and our aim was accomplished affirmatively. ESFL also significantly suppressed the formation of ACF in a dose-dependent manner.
ACF assay has been performed to assess functional substances for colon cancer prevention in many cases (5, 29, 37) . Although ACF seems to be regarded as a useful biomarker for colon cancer, it is still controversial whether ACF really are preneoplastic lesions in the colon. However, a view that the large type of ACF with more than 4 crypts per focus represents the early events in colon carcinogenesis seems to be widely accepted (2, 15, 26) and several researchers have recently provided new evidence supporting the hypothesis that ACF represent preneoplastic lesions in the colon (14, 24, 25, 35) . In our present study, we showed that ESFL was effective in the prevention of both colon cancer and ACF. Therefore, we regard ACF assay as a useful technique to evaluate the role of functional substances in foods toward cancer prevention, especially considering the fact that the assay is not time-consuming.
We have not yet proved whether ESFL contains the functional substances mentioned above. Thus, our next aim is to identify the substance(s) responsible for the inhibitory effects on colon cancer and ACF and to understand the mechanism(s) for the inhibition.
Finally, several mice died within 24 hr after the first injection of DMH. The event was observed in both the cancer experiment and the ACF one. Although the dose was decided on the basis of our pre-experiments, the administration of DMH must have been slightly overdone. Several mice died during the experiment on colon cancer and we excluded the dead ones from the evaluation. Although all the mice which had died during the colon experiment underwent autopsy, we failed to prove that colon cancer was definitely the cause of the death because of the rapid putrefaction of the gut.
All of those problems will be addressed in our next study.
